Skip to main content

Adenosine Injection Shortage

Last Updated: April 18, 2024
Status: Current

Products Affected - Description
    • Adenosine intravenous injection, Eugia US, 3 mg/mL, 20 mL vial, 1 count, NDC 55150-0192-01
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 20 mL vial, 1 count, NDC 63323-0651-20
Reason for the Shortage
    • Akorn ceased operations in February 2023.
    • Pfizer discontinued adenosine in late-2022.
    • Eugia did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Sagent has adenosine injection available.
    • Teva is not currently marketing adenosine injection.
    • Viatris has adenosine injection available.
Available Products
    • Adenosine intravenous injection, Eugia US, 3 mg/mL, 30 mL vial, 1 count, NDC 55150-0193-01
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 30 mL vial, 1 count, NDC 63323-0651-30
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 20 mL vial, 1 count, NDC 67457-0856-20
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 30 mL vial, 1 count, NDC 67457-0857-30
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL syringe, 10 count, NDC 63323-0651-89
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 2 mL vial, 10 count, NDC 63323-0651-02
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL syringe, 10 count, NDC 63323-0651-90
    • Adenosine intravenous injection, Fresenius Kabi, 3 mg/mL, 4 mL vial, 10 count, NDC 63323-0651-04
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 2 mL vial, 10 count, NDC 67457-0855-02
    • Adenosine intravenous injection, Mylan (Viatris), 3 mg/mL, 4 mL vial, 10 count, NDC 67457-0854-04
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL prefilled syringe, 10 count, NDC 25021-0301-67
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 2 mL vial, 10 count, NDC 25021-0318-02
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL prefilled syringe, 10 count, NDC 25021-0301-68
    • Adenosine intravenous injection, Sagent, 3 mg/mL, 4 mL vial, 10 count, NDC 25021-0318-04

Estimated Resupply Dates

    • Eugia has adenosine 3 mg/mL 20 mL vials on back order and the company estimates a release date of May to June 2024. Short-dated product is available.
    • Fresenius Kabi has adenosine short-dated 3 mg/mL 20 mL vials available with an expiration date of < 8 months.

Updated

Updated April 18, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 3, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer